Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-14-008393)

Filing Details

Accession Number:: 0001127602-14-008393
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-02-25 17:49:41
Reporting Period:: 2014-02-21

Filing Date:: 2014-02-25
Accepted Time:: 2014-02-25 17:49:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
850693	Allergan Inc	AGN	Pharmaceutical Preparations (2834)	951622442

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1190644	S Douglas Ingram	2525 Dupont Drive Irvine CA 92612	President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-02-21	1	$125.70	1,044	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2014-02-21	70,431	$125.07	70,431	$125.07

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
70,431		2024-02-21	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,673	Indirect	By 401(k) Trust
Common Stock	3,612	Indirect	By Esop Trust
Common Stock	22,772	Indirect	By Family Trust

Footnotes

Shares allocated to reporting person's SIP account as of reporting date.
Shares allocated to the reporting person's ESOP account as of reporting date.
The option becomes exercisable in four equal annual installments beginning February 21, 2015.